Honorhealth Research Institute
Clinical trials sponsored by Honorhealth Research Institute, explained in plain language.
-
New cocktail of chemo drugs shows promise for tough pancreatic cancer
Disease control CompletedThis study tested a combination of three chemotherapy drugs (paclitaxel protein bound, gemcitabine, and cisplatin) in 34 people with metastatic pancreatic cancer that had not been treated before. If the cancer got worse, a fourth drug (paricalcitol) was added. The goal was to see…
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
New drug cocktail shows promise against tough pancreatic cancer
Disease control CompletedThis study tested a combination of four drugs (paclitaxel protein bound, gemcitabine, cisplatin, and paricalcitol) given before surgery to people with pancreatic cancer that could be removed or was borderline removable. The goal was to see if this treatment could shrink tumors an…
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug combo targets tough pancreatic cancer in small trial
Disease control CompletedThis study tested whether two oral chemotherapy drugs, vemurafenib and sorafenib, could help people with advanced pancreatic cancer that has a specific gene change (KRAS mutation) and has stopped responding to standard treatments. Ten participants took the drug combination to see…
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New cocktail shows promise for tough pancreatic cancer
Disease control CompletedThis study tested a combination of three chemotherapy drugs (nab-paclitaxel, cisplatin, and gemcitabine) in 42 people with metastatic pancreatic cancer that had not been treated before. The goal was to see if this mix could help patients live longer and control the disease. The t…
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Rubbing alcohol sniffed away migraine nausea in small trial
Symptom relief CompletedThis study tested if inhaling isopropyl alcohol (rubbing alcohol) vapor reduces nausea during a migraine attack better than a placebo scent (eucalyptus). 21 adults with frequent migraines took part. Researchers measured changes in nausea severity and any side effects.
Phase: NA • Sponsor: HonorHealth Research Institute • Aim: Symptom relief
Last updated May 26, 2026 05:37 UTC
-
Can antioxidants help heal older brains after injury?
Symptom relief CompletedThis study looked at whether giving N-Acetylcysteine (an antioxidant) plus multivitamins to adults over 60 with a traumatic brain injury could help reduce symptoms like headaches, confusion, and emotional issues. 92 participants were treated within 3 hours of injury and followed …
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Symptom relief
Last updated May 20, 2026 11:58 UTC